Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
Title:
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
Author:
Berdeja, Jesus Jagannath, Sundar Zonder, Jeffrey Badros, Ashraf Kaufman, Jonathan L. Manges, Robert Gupta, Manish Tendolkar, Amol Lynch, Mark Bleickardt, Eric Paliwal, Prashni Vij, Ravi